Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medullary thyroid cancer.

Y Nancy You1, Vipul Lakhani, Samuel A Wells

  • 1Department of Surgery, Mayo Clinic, Gonda 12, 200 First Street SW, Rochester, MN 55905, USA.

Surgical Oncology Clinics of North America
|August 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Dedicated Care Coordination on Access to Multidimensional Support Services in Young-Onset Colorectal Cancer: A Pragmatic Trial.

JCO oncology practice·2026
Same author

Genomic analysis of T Cell receptors reveals lynch syndrome specific immune signatures.

Nature communications·2026
Same author

Construction of conditional survival nomograms for metastatic early onset colon cancer patients.

Journal of gastrointestinal oncology·2025
Same author

Tumor-infiltrating bacteria disrupt cancer epithelial cell interactions and induce cell-cycle arrest.

Cancer cell·2025
Same author

Access to and Delivery of High-Quality Cancer Care.

JAMA surgery·2025
Same author

Enhancing Standardization in the Pediatric Management of Hereditary Polyposis Syndromes.

Cancer prevention research (Philadelphia, Pa.)·2025
Same journal

Small Incisions, Big Impact-Robotic Surgery Is Revolutionizing Cancer Care.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive and Robotic Surgery for Cancer.

Surgical oncology clinics of North America·2026
Same journal

TeleSurgery: The Present and the Future for Minimally Invasive and Robotic Surgery.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive and Robotic Surgery for Rectal Cancer.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive/Robotic Surgery for Colon Cancer.

Surgical oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery in Liver Transplantation.

Surgical oncology clinics of North America·2026
See all related articles

Early detection and surgical removal are key for managing medullary thyroid carcinoma (MTC). Screening methods enable prophylactic surgery for hereditary MTC, while new therapies offer hope for advanced cases.

Area of Science:

  • Oncology
  • Genetics
  • Surgical Management

Background:

  • Medullary thyroid carcinoma (MTC) management focuses on early disease detection and complete surgical resection.
  • Hereditary MTC risk can be mitigated through tumor marker and genetic screening, facilitating prophylactic surgery.
  • While complete resection is crucial for cure, reoperation for recurrent MTC offers benefits only to select patients.

Purpose of the Study:

  • To outline the current strategies for managing medullary thyroid carcinoma.
  • To highlight the importance of early detection and surgical intervention.
  • To discuss emerging therapeutic options for advanced or metastatic MTC.

Main Methods:

  • Review of current clinical practices in MTC management.
  • Analysis of screening protocols including biochemical and genetic testing.

Related Experiment Videos

  • Evaluation of surgical outcomes and therapeutic advancements.

    • Main Results:

    • Early-stage detection and surgical removal are paramount for MTC patient outcomes.
    • Screening enables timely prophylactic surgery in individuals with hereditary MTC.
    • Targeted therapies for RET-activated pathways show promise for advanced and metastatic MTC.

    Conclusions:

    • Effective MTC management relies on early diagnosis and complete surgical resection.
    • Genetic screening plays a vital role in preventing hereditary MTC through prophylactic surgery.
    • Advancements in targeted therapies provide new hope for patients with advanced or metastatic medullary thyroid carcinoma.